Improved genetic association tests for an ordinal outcome representing the disease progression process

Genetic Epidemiology

Volumn 35, Issue 6, 2011, Pages 499-505

  Zhang, Hong ^a,b   Wacholder, Sholom ^a   Qin, Jing ^c   Hildesheim, Allan ^a   Yu, Kai ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FUDAN UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cervical cancer; Maximal score test; Ordinal response; P value combination test; Proportional odds model

Indexed keywords

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; ALGORITHMS; ALLELES; COMPUTER SIMULATION; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; MODELS, GENETIC; MODELS, STATISTICAL; MOLECULAR EPIDEMIOLOGY; ODDS RATIO; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 80051803101     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20599     Document Type: Article

References (13)

1. Agresti A. 2002. Categorical Data Analysis, 2nd edition. New Jersey: Wiley.
2. Begleiter H, Reich T, Hesselbrock V, Porjesz B, Li T, Schuckit MA, Edenberg HJ, Rice AP. 1995. The collaborative study on the genetics of alcoholism. Alcohol Health Res World 19:228-236.
3. Conneely KN, Boehnke M. 2007. So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 81:1158-1168.
4. Dudbridge F, Koeleman BP. 2004. Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies. Am J Hum Genet 75:424-435.
5. Herrero R, Schiffman MH, Bratti C, Hildesheim A, Balmaceda I, Sherman ME, Greenberg M, Cardenas F, Gomez V, Helgesen K, Morales J, Hutchinson M, Mango L, Alfaro M, Potischman NW, Wacholder S, Swanson C, Brinton LA. 1997. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1:362-375.
6. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92:464-474.
7. Hoh J, Wille A, Ott J. 2001. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res 11:2115-2119.
8. Lin DY. 2005. An efficient Monte Carlo approach to assessing statistical significance in genomic studies. Bioinformatics 21:781-787.
9. McCullagh P. 1980. Regression models for ordinal data. J R Stat Soc Ser B 42:109-142.
10. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
11. Wang SS, Bratti MC, Rodriguez AC, Herrero R, Burk RD, Porras C, Gonzalez P, Sherman ME, Wacholder S, Lan ZE, Schiffman M, Chanock SJ, Hildesheim A. 2009. Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis 199:20-30.
12. Wang SS, Gonzalez P, Yu K, Porras C, Li Q, Safaeian M, Rodriguez AC, Sherman ME, Bratti C, Schiffman M, Wacholder S, Burk RD, Herrero R, Chanock SJ, Hildesheim A. 2010. Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One 5:e8667.
13. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, Caporaso N, Kraft P, Chatterjee N. 2009. Pathway analysis by adaptive combination of P-values. Genet Epidemiol 33:700-709.